Idiopathic membranous nephropathy
- PMID: 866573
Idiopathic membranous nephropathy
Abstract
The clinical and histopathological features of 37 patients with idiopathic membranous nephropathy are presented. Males were four times as commonly affected as females and the age at presentation ranged from nine to 70 years. The period of observation varied from three months to 23 years. Twenty-eight patients (76 percent) presented with the nephrotic syndrome and nine patients (24 per cent) presented with non-nephrotic proteinuria. At the end of the study, of the patients presenting with the nephrotic syndrome, seven (25 per cent) were in remission, seven (25 per cent) remained nephrotic, nine (32 per cent) showed only proteinuria and five (18 per cent) were dead or on dialysis. Altogether eight patients (28 per cent) developed renal failure. The nine patients who presented with non-nephrotic proteinuria appeared to do better, and none developed renal failure. The occurrence of spontaneous remission makes assessment of benefit from immunosuppressive therapy difficult. However, analysis of our data and a review of the literature suggest that in this condition oral prednisone, cyclophosphamide and azathioprine have no significant therapeutic properties. Histological assessment confirmed the occurrence of mild (Grade 1) changes in patients biopsied soon after presentation, and tubular atrophy increased with the duration of illness. Immunofluorescence confirmed deposition of mainly IgG and complement. Repeat biopsies in 14 patients showed no histological improvement and remission was not accompanied by resolution of histological abnormalities.
Similar articles
-
Membranous nephropathy. Long-term follow-up and association with neoplasia.Q J Med. 1975 Apr;44(174):207-39. Q J Med. 1975. PMID: 1178811
-
Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.Clin Nephrol. 1996 Oct;46(4):237-44. Clin Nephrol. 1996. PMID: 8905208
-
Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.Clin Nephrol. 1986 Oct;26(4):174-80. Clin Nephrol. 1986. PMID: 3536231 Clinical Trial.
-
[Membranous nephropathy].Rev Prat. 2003 Nov 30;53(18):2033-8. Rev Prat. 2003. PMID: 15008218 Review. French.
-
Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy?J Nephrol. 2010 Mar-Apr;23(2):156-63. J Nephrol. 2010. PMID: 20213607 Review.
Cited by
-
Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis.Clin Investig. 1994 Mar;72(4):277-82. doi: 10.1007/BF00180040. Clin Investig. 1994. PMID: 8043974 Clinical Trial.
-
A Genetic Risk Score Distinguishes Different Types of Autoantibody-Mediated Membranous Nephropathy.Glomerular Dis. 2023 Mar 13;3(1):116-125. doi: 10.1159/000529959. eCollection 2023 Jan-Dec. Glomerular Dis. 2023. PMID: 37090184 Free PMC article.
-
Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).Int Urol Nephrol. 1988;20(3):315-25. doi: 10.1007/BF02549523. Int Urol Nephrol. 1988. PMID: 3403200
-
Idiopathic membranous glomerulonephritis: aspects of geographical differences.J Clin Pathol. 1986 Nov;39(11):1193-8. doi: 10.1136/jcp.39.11.1193. J Clin Pathol. 1986. PMID: 3793935 Free PMC article.
-
Genetics of membranous nephropathy.Nephrol Dial Transplant. 2018 Sep 1;33(9):1493-1502. doi: 10.1093/ndt/gfx296. Nephrol Dial Transplant. 2018. PMID: 29126273 Free PMC article. Review.